Cargando…

Triclabendazole Sulfoxide Causes Stage-Dependent Embryolethality in Zebrafish and Mouse In Vitro

BACKGROUND: Fascioliasis and paragonimiasis are widespread foodborne trematode diseases, affecting millions of people in more than 75 countries. The treatment of choice for these parasitic diseases is based on triclabendazole, a benzimidazole derivative which has been suggested as a promising drug t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boix, Nuria, Teixido, Elisabet, Vila-Cejudo, Marta, Ortiz, Pedro, Ibáñez, Elena, Llobet, Juan M., Barenys, Marta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4368200/ https://www.ncbi.nlm.nih.gov/pubmed/25793498 http://dx.doi.org/10.1371/journal.pone.0121308

Ejemplares similares

Cardiovascular Effects of PCB 126 (3,3’,4,4’,5-Pentachlorobiphenyl) in Zebrafish Embryos and Impact of Co-Exposure to Redox Modulating Chemicals
por: Teixidó, Elisabet, et al.
Publicado: (2019)

Modulation and Protection Effects of Antioxidant Compounds against Oxidant Induced Developmental Toxicity in Zebrafish
por: Boix, Nuria, et al.
Publicado: (2020)

The Differences in the Susceptibility Patterns to Triclabendazole Sulfoxide in Field Isolates of Fasciola hepatica Are Associated with Geographic, Seasonal, and Morphometric Variations
por: Fernandez-Baca, Martha V., et al.
Publicado: (2022)

In Vitro Drug-Drug Interaction Potential of Sulfoxide and/or Sulfone  Metabolites of Albendazole, Triclabendazole, Aldicarb, Methiocarb, Montelukast and Ziprasidone
por: Giri, Poonam, et al.
Publicado: (2018)

First-Generation Synthetic Cathinones Produce Arrhythmia in Zebrafish Eleutheroembryos: A New Approach Methodology for New Psychoactive Substances Cardiotoxicity Evaluation
por: Teixidó, Elisabet, et al.
Publicado: (2023)

The Zebrafish Embryo as a Model to Test Protective Effects of Food Antioxidant Compounds
por: Arteaga, Cristina, et al.
Publicado: (2021)

Triclabendazole in the treatment of human fascioliasis: a review
por: Gandhi, Preetam, et al.
Publicado: (2019)

Unchanged triclabendazole kinetics after co-administration with ivermectin and methimazole: failure of its therapeutic activity against triclabendazole-resistant liver flukes
por: Ceballos, Laura, et al.
Publicado: (2010)

In vitro anti-Leishmania activity of triclabendazole and its synergic effect with amphotericin B
por: Borges, Beatriz Santana, et al.
Publicado: (2023)

Apparent Triclabendazole-Resistant Human Fasciola hepatica Infection, the Netherlands
por: Winkelhagen, Annemarie J.S., et al.
Publicado: (2012)

Triclabendazole Effect on Protease Enzyme Activity in the Excretory- Secretory Products of Fasciola hepatica in Vitro
por: SHRIFI, Yosef, et al.
Publicado: (2014)

Chitosan-based nanodelivery systems applied to the development of novel triclabendazole formulations
por: Real, Daniel, et al.
Publicado: (2018)

Evidence of sequestration of triclabendazole and associated metabolites by extracellular vesicles of Fasciola hepatica
por: Davis, Chelsea N., et al.
Publicado: (2020)

Administration of Triclabendazole Is Safe and Effective in Controlling Fascioliasis in an Endemic Community of the Bolivian Altiplano
por: Villegas, Fidel, et al.
Publicado: (2012)

Confirmation of Fasciola hepatica resistant to triclabendazole in naturally infected Australian beef and dairy cattle()
por: Brockwell, Yvette M., et al.
Publicado: (2013)

Pilot Evaluation of Two Fasciola hepatica Biomarkers for Supporting Triclabendazole (TCBZ) Efficacy Diagnostics
por: Collett, Clare F., et al.
Publicado: (2020)

Evaluation of nitazoxanide treatment following triclabendazole failure in an outbreak of human fascioliasis in Upper Egypt
por: Ramadan, Haidi Karam-Allah, et al.
Publicado: (2019)

Repurposing of the Fasciolicide Triclabendazole to Treat Infections Caused by Staphylococcus spp. and Vancomycin-Resistant Enterococci
por: Pi, Hongfei, et al.
Publicado: (2021)

Triclabendazole Induces Pyroptosis by Activating Caspase-3 to Cleave GSDME in Breast Cancer Cells
por: Yan, Liang, et al.
Publicado: (2021)

A major locus confers triclabendazole resistance in Fasciola hepatica and shows dominant inheritance
por: Beesley, Nicola J., et al.
Publicado: (2023)

Correction: Evaluation of nitazoxanide treatment following triclabendazole failure in an outbreak of human fascioliasis in Upper Egypt
por: Ramadan, Haidi Karam-Allah, et al.
Publicado: (2020)

The soluble glutathione transferase superfamily: role of Mu class in triclabendazole sulphoxide challenge in Fasciola hepatica
por: Stuart, Rebekah B., et al.
Publicado: (2021)

The effects of dimethyl sulfoxide and ethylene glycol as vitrification protectants on different cleavage stages of mouse embryo quality
por: Ghorbani, Mina, et al.
Publicado: (2012)

A Paragonimiasis Patient with Allergic Reaction to Praziquantel and Resistance to Triclabendazole: Successful Treatment after Desensitization to Praziquantel
por: Kyung, Sun Young, et al.
Publicado: (2011)

The Small Molecule Triclabendazole Decreases the Intracellular Level of Cyclic AMP and Increases Resistance to Stress in Saccharomyces cerevisiae
por: Lee, Yong Joo, et al.
Publicado: (2013)

The Anti-Fasciolasis Properties of Silver Nanoparticles Produced by Trichoderma harzianum and Their Improvement of the Anti-Fasciolasis Drug Triclabendazole
por: Gherbawy, Youssuf A., et al.
Publicado: (2013)

Screening anthelmintic resistance to triclabendazole in Fasciola hepatica isolated from sheep by means of an egg hatch assay
por: Robles-Pérez, David, et al.
Publicado: (2015)

Triclabendazole (Anthelmintic Drug) Effects on the Excretory- Secretory Proteome of Fasciola hepatica in Two Dimension Electrophoresis Gel
por: FARIDI, Ashkan, et al.
Publicado: (2014)

Lack of efficacy of triclabendazole against Fasciola hepatica is present on sheep farms in three regions of England, and Wales
por: Kamaludeen, Juriah, et al.
Publicado: (2019)

Triclabendazole Treatment Failure for Fasciola hepatica Infection among Preschool and School-Age Children, Cusco, Peru
por: Morales, Maria L., et al.
Publicado: (2021)

Dibenzyl sulfoxide
por: Zeng, Yun-Xiu, et al.
Publicado: (2010)

Treatment Failure after Multiple Courses of Triclabendazole among Patients with Fascioliasis in Cusco, Peru: A Case Series
por: Cabada, Miguel M., et al.
Publicado: (2016)

Clonal amplification of Fasciola hepatica in Galba truncatula: within and between isolate variation of triclabendazole-susceptible and -resistant clones
por: Hodgkinson, Jane E., et al.
Publicado: (2018)

Effects of dimethyl sulfoxide on asymmetric division and cytokinesis in mouse oocytes
por: Zhou, Dongjie, et al.
Publicado: (2014)

Dimethyl Sulfoxide Decreases Levels of Oxylipin Diols in Mouse Liver
por: Deol, Poonamjot, et al.
Publicado: (2019)

Automated Morphological Feature Assessment for Zebrafish Embryo Developmental Toxicity Screens
por: Teixidó, Elisabet, et al.
Publicado: (2019)

Editorial: Methods and protocols in neurotoxicology
por: Fritsche, Ellen, et al.
Publicado: (2022)

Discovery and Rational Mutagenesis of Methionine Sulfoxide Reductase Biocatalysts To Expand the Substrate Scope of the Kinetic Resolution of Chiral Sulfoxides
por: Anselmi, Silvia, et al.
Publicado: (2023)

Adverse effects of routine bovine health treatments containing triclabendazole and synthetic pyrethroids on the abundance of dipteran larvae in bovine faeces
por: Gilbert, Gillian, et al.
Publicado: (2019)

Dimethyl Sulfoxide (DMSO) Exacerbates Cisplatin-induced Sensory Hair Cell Death in Zebrafish (Danio rerio)
por: Uribe, Phillip M., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_tu4s1hrqvdce2kslgvouapi36s